The estimated Net Worth of Thomas Ciulla is at least $1.03 Million dollars as of 20 January 2023. Dr Ciulla owns over 13,700 units of Clearside Biomedical Inc stock worth over $382,376 and over the last 4 years he sold CLSD stock worth over $59,315. In addition, he makes $589,766 as Chief Medical Officer & Chief Devel. Officer at Clearside Biomedical Inc.
Dr has made over 4 trades of the Clearside Biomedical Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 13,700 units of CLSD stock worth $20,139 on 20 January 2023.
The largest trade he's ever made was selling 13,700 units of Clearside Biomedical Inc stock on 20 January 2023 worth over $20,139. On average, Dr trades about 3,926 units every 69 days since 2021. As of 20 January 2023 he still owns at least 291,890 units of Clearside Biomedical Inc stock.
You can see the complete history of Dr Ciulla stock trades at the bottom of the page.
Dr. Thomas A. Ciulla M.B.A., M.D. is the Chief Medical Officer & Chief Devel. Officer at Clearside Biomedical Inc.
As the Chief Medical Officer & Chief Devel. Officer of Clearside Biomedical Inc, the total compensation of Dr D at Clearside Biomedical Inc is $589,766. There are 4 executives at Clearside Biomedical Inc getting paid more, with George Lasezkay having the highest compensation of $1,059,190.
Dr D is 57, he's been the Chief Medical Officer & Chief Devel. Officer of Clearside Biomedical Inc since . There are 7 older and 5 younger executives at Clearside Biomedical Inc. The oldest executive at Clearside Biomedical Inc is Nancy Hutson, 70, who is the Independent Director.
Thomas's mailing address filed with the SEC is C/O CLEARSIDE BIOMEDICAL, INC., 900 NORTH POINT PARKWAY, SUITE 200, ALPHARETTA, GA, 30005.
Over the last 8 years, insiders at Clearside Biomedical Inc have traded over $11,999,807 worth of Clearside Biomedical Inc stock and bought 4,477,928 units worth $22,264,136 . The most active insiders traders include Bradford T Whitmore, Clay Thorp und Venture Advisors Iv Sbic, L.... On average, Clearside Biomedical Inc executives and independent directors trade stock every 30 days with the average trade being worth of $82,593. The most recent stock trade was executed by Ngai Hang Victor Chong on 24 June 2024, trading 23,500 units of CLSD stock currently worth $24,910.
clearside biomedical, inc. is a pharmaceuticals company located in 1220 old alpharetta rd., suite 300, alpharetta, ga, united states.
Clearside Biomedical Inc executives and other stock owners filed with the SEC include: